Medical Device Regulations

Explore the medical device regulatory landscape, from research and development through FDA approval, manufacturing, and post-market surveillance, and how feedback drives the product lifecycle.

Explore the definition of medical devices with everyday examples like stethoscopes, pulse oximeters, imaging, and laser therapy, and understand how context and FDA regulation determine their classification.

Explore how medical device regulations operate within administrative law of the federal executive branch, led by the FDA, and are organized by the U.S. code and CFR.

Trace the history of medical device regulation from early acts to modern FDA authority, device classification, and postmarket surveillance, including UDI and key amendments.

Trace the FDA's authority from the Food, Drug and Cosmetic Act to title 21 of the Code of Federal Regulations, outlining device registration, 510(k), PMA, and IDE.

Explore the FDA structure and authority under title 21, including device registration, quality system regulations, labeling, and premarket pathways like 510(k), PMA, and IDE.

Explore how medical devices reach the market through risk-based classification and pathways such as 510(k) clearance, PMA, de novo, plus HD, EU, IDE, and postmarket monitoring.

Learn how the FDA's three-tier risk-based classification determines intended use, indications for use, and the testing and design controls required, shaping 510(k) and PMA market pathways.

Master the 510(k) clearance pathway for class 1 and 2 devices, compare it with PMA, and determine substantial equivalence to a legally marketed predicate using intended use, characteristics, and data.

Identify a predicate for your device and search for similar devices to determine the 510(k) pathway. Assess risk, testing, and patent considerations to support substantial equivalence.

Explore FDA medical device databases to find information on devices, including the 510 k premarket notification, PMA, de novo, and product classification databases.

Explore human clinical trials as evidence for medical device applications, noting cost, duration, and when trials are required or avoided, including trial types and the investigational device exemption program.

Explore the investigational device exemption (ide) under 21 CFR Part 12, detailing fda approval for human use in clinical studies and the progression from feasibility to pivotal trials.

Master the IDE submission process and early FDA engagement to shape device development, including preparing the investigational plan, study sites, labeling, and consent materials.

Identify and manage records for investigational device studies by planning cloud-based storage, coordinating sponsor-led site access, and submitting FDA progress reports with adverse events and protocol changes.

Explore how to search and download clinical trials data on clinicaltrials.gov for medical devices, using basic and advanced filters, viewing study details, and exporting to Excel.

Explore medical device quality systems, including design controls, verification, validation, and production controls, with emphasis on design history file and ISO 1345 aligned GXP regulations.

Master risk management for medical devices by integrating risk analysis, hazard identification, and controls across the design process, with human factors, documentation, and post-market surveillance.

Explore the GXP family—GMP, GOP, and GCP—and how bench testing, clinical trial practices, and manufacturing processes ensure quality from development to market for medical devices.

Describe how GLP/GOP standards govern laboratory testing for FDA submissions, including defined protocols, SOPs, data traceability, training, and documentation, while excluding preclinical research data.

Apply good clinical practices to design and conduct device studies, ensure data quality for FDA submissions, and comply with 21 CFR parts 50, 56, 54, 11, IRBs, IDE, and HIPAA.

Ensure product quality by applying GMP and good manufacturing practices across personnel, environment, equipment, materials, and processes, with traceability, controlled records, calibration, maintenance logs, and document controls.

Manage the medical device supply chain by selecting and monitoring suppliers, maintaining purchasing data, and enforcing approved products and reagents. Follow 21 CFR 20 acceptance with receipt-to-final inspection and labeling.

Understand how design controls ensure safety and quality in medical device development, detailing planning, inputs and outputs, verification, validation, and lifecycle transfer under 21 CFR part 820.

Define design inputs as the device's performance and physical requirements drawn from user needs, intended use, and regulatory requirements to guide development and testing.

Define design inputs and design outputs with acceptance criteria to ensure the device conforms to specifications and meets user needs, by verification, validation, and documentation in the device master record.

Verify design outputs meet input requirements and validate that the device fulfills user needs and intended use under defined conditions, aligning with design control and design history file documentation.

Conduct formal, documented design reviews to translate final designs into production specifications and ensure the transfer to manufacturing meets user requirements, inputs, and outputs through verification and validation.

Explore design changes within a formal change control process requiring approval, documentation, validation, and review, tracked in the design history file under quality system to protect safety and regulatory compliance.

Learn how design history file, device master record, and device history record differ and function in FDA regulation, capturing design changes, verification and validation, final manufacturing instructions, and batch history.

Navigate the FDA medical device submission process, from the paper stack to approval, and engage early on pre-submission processes, traditional, abbreviated, and special 510(k) formats, and PMA submissions.

Navigate FDA interactions through formal meetings such as the PMA 100-day meeting, pre-submission and informal discussions, and substantive reviews, and prepare briefing packages with 3–10 questions.

Explore traditional, abbreviated, and special 510(k) submissions, and the acceptance and substantial equivalence decisions that determine clearance, including guidance on content, predicate selection, and early FDA engagement.

Learn the traditional 510(k) submission content, including general information, indications for use, device and predicate details, performance data, labeling, and the substantial equivalence review.

Learn when to use the abbreviated 510(k) for devices with clear standards, relying on guidance documents, special controls, and recognized standards to show substantial equivalence.

Identify when to use a special 510 K for modifications to an already marketed device by the original manufacturer. Confirm eligibility with four basic questions and risk analysis data.

Learn how PMA submissions for class III devices compile nonclinical and clinical data, device description, manufacturing details, and safety and effectiveness conclusions, with 100-day FDA review and final decision memo.

Learn how to communicate changes to medical devices, choosing among letter to file, special 510(k), traditional 510(k), and PMA submissions while assessing risk, labeling, materials, and patient population implications.

Study postmarket surveillance after a device’s release to identify safety events, use findings as design requirements, and apply complaints, adverse events, medical device reports, and recalls to guide action.

Identify and respond to adverse events through medical device reports and complaint handling. Learn FDA MDR filing, MedWatch use, and root-cause analysis to classify, investigate, and document safety issues.

Define recalls and related concepts, including removals, corrections, market withdrawals, and stock recoveries, and distinguish class one, two, and three recalls as voluntary or mandatory by the FDA.

Understand how 21 CFR 522 mandates postmarket surveillance for class two or three devices, including life-sustaining implants, with FDA oversight, 60-day responses, and design, tracking, and implementation studies.